These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 34958805

  • 1. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
    Chen C, Cui P, Zhao K, Niu G, Hou S, Zhao D, Zeng H.
    Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
    [Abstract] [Full Text] [Related]

  • 2. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
    Hou S, Niu G, Liu X, Bourbon PM, Zhang D, Cui P, Zhao K, Zhao D, Zeng H.
    Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
    [Abstract] [Full Text] [Related]

  • 3. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
    Cui P, Liu X, Zhao K, Hou S, Chen C, Zhao D, Zeng H.
    Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J, Lee JC, Baek KH.
    Cancer Lett; 2014 Jan 01; 342(1):70-81. PubMed ID: 24051307
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
    Yao YG, Duh EJ.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):648-56. PubMed ID: 15358155
    [Abstract] [Full Text] [Related]

  • 11. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K.
    Mol Cancer; 2014 Apr 26; 13():88. PubMed ID: 24766647
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis.
    Iizuka M, Abe M, Shiiba K, Sasaki I, Sato Y.
    J Vasc Res; 2004 Apr 26; 41(4):334-44. PubMed ID: 15263820
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
    Bartolomé RA, Torres S, Isern de Val S, Escudero-Paniagua B, Calviño E, Teixidó J, Casal JI.
    Oncotarget; 2017 Jan 03; 8(1):215-227. PubMed ID: 27966446
    [Abstract] [Full Text] [Related]

  • 16. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
    Hesser BA, Liang XH, Camenisch G, Yang S, Lewin DA, Scheller R, Ferrara N, Gerber HP.
    Blood; 2004 Jul 01; 104(1):149-58. PubMed ID: 15016650
    [Abstract] [Full Text] [Related]

  • 17. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.
    Nature; 2009 Jun 25; 459(7250):1126-30. PubMed ID: 19458618
    [Abstract] [Full Text] [Related]

  • 18. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, Wang P, He GJ, Hao B, Shi RH.
    World J Gastroenterol; 2014 Dec 21; 20(47):17894-904. PubMed ID: 25548487
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.
    Mo Y, Fang RH, Wu J, Si Y, Jia SQ, Li Q, Bai JZ, She XN, Wang JQ.
    J Cell Physiol; 2019 Dec 21; 234(12):23518-23527. PubMed ID: 31219186
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.